ARQT - Company ID 0001787306
The table below shows Arcutis Biotherapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $33.37M | $34.12M | $34.76M | $47.12M | $72.74M | $53.10M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $171.28M | $155.16M | $144.38M | $115.12M | $106.69M | $85.42M |
| Inventory | $45.67M | $38.88M | $37.39M | $22.42M | $16.32M | $16.61M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $503.69M |
| $467.67M |
| $438.06M |
| $349.22M |
| $332.78M |
| $323.67M |
| Property, plant & equipment | $796.00K | $872.00K | $1.04M | $1.22M | $1.39M | $1.50M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $524.43M | $488.54M | $460.00M | $370.98M | $352.43M | $344.11M |
| Accounts payable | $8.34M | $6.60M | $18.30M | $5.79M | $15.08M | $24.53M |
| Total current liabilities | $172.36M | $160.34M | $163.20M | $99.77M | $103.94M | $91.13M |
| Long-term debt | $102.45M | $101.95M | $101.47M | $107.50M | $107.05M | $107.62M |
| Total liabilities | $280.46M | $267.96M | $270.36M | $212.90M | $213.46M | $201.45M |
| Retained earnings | -$1.13B | -$1.13B | -$1.15B | -$1.16B | -$1.16B | -$1.15B |
| Total equity | $243.97M | $220.58M | $189.65M | $158.07M | $138.97M | $142.66M |